Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Self-Management » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

A Healthy Diet Controls Blood Sugars Better than Drugs
Posted: Monday, August 02, 2010
A healthier diet helps control high risk Type 2 diabetes better than what drugs can achieve alone.

FDA Advisory Committee Votes to Keep Rosiglitazone on the Market
Posted: Sunday, July 25, 2010
Thirty-three members of the US Food and Drug Administration (FDA) cast 20 votes for various label options that would allow GlaxoSmithKline's rosiglitazone (Avandia) to stay on the market despite concerns over associated heart risks, while 12 members voted to recommend that the FDA withdraw the drug.

Pre-existing Conditions Covered by New High-Risk Insurance Pools
Posted: Sunday, July 11, 2010
Beginning July 1, individuals with pre-existing health conditions as diabetes are eligible to enroll in a temporary high-risk insurance pool, courtesy of the health care reform law.

Study Finds Visually Impaired People Get Insulin Pen Dosages Right
Posted: Sunday, July 11, 2010
Study shows visually impaired people can use insulin pens even though the labels on the popular insulin pen used by people with diabetes warn against visually-impaired people using pens to measure out and administer their insulin dosage.

Diabetes and Cardiology Groups Stay Firm on Rosiglitazone
Posted: Sunday, July 04, 2010
In response to new Medicare data showing greater elevations in stroke, heart failure, and death risk with rosiglitazone compared with pioglitazone (Actos), the AHA issued a statement to the media reiterating its stance that there are insufficient data to support the choice of one over the other. And both the AHA and the ADA emphasized the need for patients to be informed of the new evidence, but not to panic.

Mortality Lower with Metformin
Posted: Sunday, July 04, 2010
Metformin use may reduce mortality by 33% among patients with Type 2 diabetes who are at risk for cardiovascular events, researchers say.

Diabetes Care Management Program Lowers Health Care Costs, Hospitalization Rates
Posted: Sunday, June 27, 2010
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds.

Vitamin E Reduces Cardiovascular Disease in Individuals with Diabetes
Posted: Sunday, June 13, 2010
The study shows that individuals with both diabetes and the Haptoglobin (Hp) 2-2 genotype can benefit from using Vitamin E, increasing life expectancy by 3 years.

Experts Advise Beginning Daily Aspirin Later
Posted: Sunday, June 06, 2010
In a change, heart and diabetes groups push age threshold up from 40, to 50 for men, 60 for women.

New Device Predicts Diabetic Wound Healing
Posted: Sunday, June 06, 2010
A new breakthrough device developed by researchers can change the current landscape of chronic wound management.

Page 9 of 63
 |<   <<   <  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  >   >>   >| 

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement